A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
More specific conditions that are subtypes of Trastuzumab in the MeSH hierarchy.
1 drug approved
Phase 3 trials (2)
Other trials (1)